Investment Stage

Focus Areas

About Investor

Alice Lin Pomponio is Managing Director of BrightEdge, the American Cancer Society’s impact-investment and venture philanthropy fund. She typically invests $100K–$5.0M at pre-seed and seed into oncology-focused biotech, therapeutics, medical devices, digital health and related wellness/fintech models that can both scale commercially and advance health equity for cancer patients. Her career spans more than two decades in life sciences and policy, including leadership roles at Radius Health, AstraZeneca and Genzyme/Sanofi, founding Accendo Capital Group, and policy and advocacy work around global health and trade. She also holds board roles with organizations such as MassBio and MassBiologics and serves as a senior innovation and impact leader within the American Cancer Society.